DENVER, Feb. 28, 2011 (GLOBE NEWSWIRE) -- MusclePharm Corporation, a Nevada corporation ("MusclePharm" or the "Company") (OTCBB:MSLP), an expanding U.S. nutritional supplement company, is pleased to announce that it will be the official supplement provider of the Xempt Player Series (XPS), a new professional golf tour that will debut in April 2011.
The Xempt Player Series is open to men, women and seniors who have aspirations of playing professional golf. The debuting series will feature participants competing from all over the United States, with each participant vying for part of the $200,000 total purse that is up for grabs at the XPS Championship in August.
MusclePharm's sponsorship of the XPS also signals the introduction of its innovative MuscleGel product into the golf market. Each professional golfer at all 31 nationwide XPA tournaments will receive MuscleGel during tournament play. The convenient gel-based formula, which has drawn favorable reviews since its introduction, offers high-quality protein that can be consumed on the go without liquids or mixing.
"The XPS is a tour that is great for an aspiring golfer who is trying to make it to the next level and I am very excited to have a major brand like MusclePharm on board to support their dream of playing professional golf," XPS CEO and Founder Gerry Hammond said. "MuscleGel is one of the best products I have ever used and it will be perfect in a golf-tour setting. These players need something light that they can carry with them on the course, and MuscleGel is an incredibly convenient and high-quality product."
The XPS' stroke play competition will start with as many as 120 golfers competing at each local XPS qualifying tournament across the United States. Those who qualify will then take part in one of five regional qualifier tournaments, with 24 players advancing from each region to the year-end XPS championship. The XPS champion will win more than $86,000 in prize money and benefits, making it an ideal stage for MusclePharm to introduce Muscle Gel to the golf marketplace.
"MusclePharm considers itself 'The Athlete's Company' and our goal is to make an impact in every sport. We are excited to be working with the XPS and we look forward to its launch in April," MusclePharm President Cory Gregory said. "This grassroots approach will help get MuscleGel into golfer's hands and we are confident they will like the product. It will be an easy and convenient way for the golf community to get protein during their match play, as well being a great recovery tool for these athletes after playing as much as 36 holes over two days."
For more information on the XPS, visit .
About MusclePharm Corporation
Headquartered in Denver, Colorado, MusclePharm is a healthy life-style company that develops and manufactures a full line of National Science Foundation approved nutritional supplements that are 100% free of banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts, and Major League Baseball. The Company's products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets, including GNC and Vitamin Shoppe. MusclePharm products are also sold in over 100 online stores, including bodybuilding.com, Amazon.com and Vitacost.com. For more information, please visit www.musclepharm.com.
Forward Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
CONTACT: Investor Contact: Cory Gregory, President investors@musclepharm.com